{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:52:10Z","timestamp":1773276730244,"version":"3.50.1"},"reference-count":89,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,6,1]]},"DOI":"10.1086\/421400","type":"journal-article","created":{"date-parts":[[2004,6,2]],"date-time":"2004-06-02T21:28:31Z","timestamp":1086211711000},"page":"S376-S387","source":"Crossref","is-referenced-by-count":93,"title":["Developing a Directly Administered Antiretroviral Therapy Intervention for HIV-Infected Drug Users: Implications for Program Replication"],"prefix":"10.1093","volume":"38","author":[{"given":"Frederick L.","family":"Altice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo Anne","family":"Mezger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Marinovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra A.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald H.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,6,1]]},"reference":[{"key":"key\n\t\t\t\t20171014010242_ref1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014010242_ref2","first-page":"1","article-title":"The epidemiology of HIV and AIDS in the United States","volume":"98","author":"Ward","year":"1997","journal-title":"AIDS Clin Rev"},{"key":"key\n\t\t\t\t20171014010242_ref3","first-page":"592","article-title":"Update: AIDS\u2014United States, 2000","volume":"51","author":"Centers for Disease Control Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014010242_ref4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00042560-199912010-00008","article-title":"A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival","volume":"22","author":"Mocroft","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014010242_ref5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00002030-200107060-00012","article-title":"Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA","volume":"15","author":"Goedert","year":"2001","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014010242_ref6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archinte.160.3.365","article-title":"Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997","volume":"160","author":"Whitman","year":"2000","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171014010242_ref7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/CDLI.3.1.51-60.1996","article-title":"Predictors of survival in human immunodeficiency virus type 1-seropositive intravenous drug users","volume":"3","author":"Page","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"key\n\t\t\t\t20171014010242_ref8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-200203290-00012","article-title":"Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic","volume":"16","author":"Lucas","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014010242_ref9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archinte.160.3.365","article-title":"Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997","volume":"160","author":"Whitman","year":"2000","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171014010242_ref10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00002030-200106150-00006","article-title":"Differences in HIV disease progression by injecting drug users in the era of highly active antiretroviral therapy","volume":"15","author":"Poundstone","year":"2001","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014010242_ref11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1081\/ADA-100100600","article-title":"Adherence to antiretroviral therapy among HIV-infected methadone patients: effects of ongoing illicit drug user","volume":"26","author":"Stein","year":"2000","journal-title":"Am J Drug Alcohol Abuse"},{"key":"key\n\t\t\t\t20171014010242_ref12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00042560-199912150-00006","article-title":"Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors","volume":"22","author":"Murri","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014010242_ref13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00042560-200002010-00010","article-title":"Trends in prescriptions for highly active antiretroviral therapy in four New York City HIV clinics","volume":"23","author":"Sackoff","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014010242_ref14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.279.24.1977","article-title":"Public health implications of antiretroviral therapy and HIV drug resistance","volume":"279","author":"Wainberg","year":"1998","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014010242_ref15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/10872910252806117","article-title":"Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine","volume":"16","author":"Zaccarelli","year":"2002","journal-title":"AIDS Patient Care STDs"},{"key":"key\n\t\t\t\t20171014010242_ref16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002030-200202150-00008","article-title":"Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)","volume":"16","author":"Cingolani","year":"2002","journal-title":"AIDS"},{"issue":"Suppl 3","key":"key\n\t\t\t\t20171014010242_ref17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/135965350100603S02","article-title":"The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population","volume":"6","author":"Pillay","year":"2001","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20171014010242_ref18","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1089\/088922299309676","article-title":"Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort","volume":"15","author":"Paris","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20171014010242_ref19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM199807303390504","article-title":"Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors","volume":"339","author":"Hecht","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014010242_ref20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2000.tb05467.x","article-title":"The role of antiretrovirals and drug resistance in vertical transmission of HIV-1 infection","volume":"918","author":"Brenner","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t20171014010242_ref21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<181::AID-JMV2>3.0.CO;2-T","article-title":"Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection","volume":"61","author":"Tamalet","year":"2000","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20171014010242_ref22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199807303390511","article-title":"Transmission of multidrug-resistant human immunodeficiency virus\u2014the wake-up call","volume":"339","author":"Cohen","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014010242_ref23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0740-5472(97)00220-1","article-title":"Can syringe exchange serve as a conduit to substance abuse treatment?","volume":"15","author":"Heimer","year":"1998","journal-title":"J Subst Abuse Treat"},{"key":"key\n\t\t\t\t20171014010242_ref24","first-page":"59","article-title":"Three years of needle exchange in New Haven: what have we learned?","volume":"9","author":"Heimer","year":"1994","journal-title":"AIDS Public Policy J"},{"key":"key\n\t\t\t\t20171014010242_ref25","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00002030-200009080-00020","article-title":"Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus","volume":"14","author":"Shah","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014010242_ref26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jurban\/79.1.113","article-title":"Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program","volume":"79","author":"Riley","year":"2002","journal-title":"J Urban Health"},{"key":"key\n\t\t\t\t20171014010242_ref27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1525-1446.2002.19504.x","article-title":"Effectiveness of a mobile medical van in providing screening services for STDs and HIV","volume":"19","author":"Liebman","year":"2002","journal-title":"Public Health Nurs"},{"key":"key\n\t\t\t\t20171014010242_ref28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11606-002-0037-2","article-title":"The impact of needle exchange-based health services on emergency department use","volume":"17","author":"Pollack","year":"2002","journal-title":"J Gen Intern Med"},{"key":"key\n\t\t\t\t20171014010242_ref29","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2105\/AJPH.91.11.1791","article-title":"Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program","volume":"91","author":"Des Jarlais","year":"2001","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20171014010242_ref30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/jurban\/jtg053","article-title":"Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users","volume":"80","author":"Altice","year":"2003","journal-title":"J Urban Health"},{"key":"key\n\t\t\t\t20171014010242_ref31","first-page":"305","article-title":"Directly observed antiretroviral therapy for injection drug users with HIV infection","volume":"12","author":"Clarke","year":"2002","journal-title":"AIDS Reader"},{"key":"key\n\t\t\t\t20171014010242_ref32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/02791072.1988.10524497","article-title":"Treatment of intravenous drug users with AIDS: the role of methadone maintenance","volume":"20","author":"Batki","year":"1988","journal-title":"J Psychoactive Drugs"},{"key":"key\n\t\t\t\t20171014010242_ref33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0376-8716(94)01080-5","article-title":"Adherence to zidovudine (AZT) among methadone maintenance patients: on-site dispensing compared to usual care","volume":"37","author":"Wall","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"key\n\t\t\t\t20171014010242_ref34","article-title":"Directly administered antiretroviral therapy (DAART) in a methadone maintenance clinic improves HIV outcomes [abstract 489]","volume-title":"Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego)","author":"Lucas","year":"2002"},{"key":"key\n\t\t\t\t20171014010242_ref35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF02351504","article-title":"Evaluating supervised HAART in late-stage HIV among drug users: a preliminary report","volume":"76","author":"Greenberg","year":"1999","journal-title":"J Urban Health"},{"key":"key\n\t\t\t\t20171014010242_ref36","article-title":"Impact of directly observed therapy on long-term outcomes in HIV clinical trials [abstract 528]","volume-title":"8th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Chicago)","author":"Fischl","year":"2001"},{"key":"key\n\t\t\t\t20171014010242_ref37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1086\/338400","article-title":"Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment","volume":"34","author":"Kirkland","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014010242_ref38","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1086\/375076","article-title":"Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates","volume":"36","author":"Wohl","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014010242_ref39","first-page":"317","article-title":"Enhancing adherence to HAART: modified directly observed therapy","volume":"11","author":"Stenzel","year":"2001","journal-title":"AIDS Reader"},{"key":"key\n\t\t\t\t20171014010242_ref40","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/339447","article-title":"Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress","volume":"34","author":"Mitty","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014010242_ref41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2105\/AJPH.88.3.442","article-title":"The influence of program acceptability on the effectiveness of public health policy: a study of directly observed therapy for tuberculosis","volume":"88","author":"Heymann","year":"1998","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20171014010242_ref42","first-page":"319","article-title":"Implications of directly observed therapy in tuberculosis control measures among IDUs","volume":"109","author":"Curtis","year":"1994","journal-title":"Public Health Rep"},{"key":"key\n\t\t\t\t20171014010242_ref43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0272-5231(05)70363-4","article-title":"Directly observed therapy in New York City. History, implementation, results, and challenges","volume":"18","author":"Fujiwara","year":"1997","journal-title":"Clin Chest Med"},{"key":"key\n\t\t\t\t20171014010242_ref44","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jama.1995.03530120037038","article-title":"Eleven years of community-based directly observed therapy for tuberculosis","volume":"274","author":"Chaulk","year":"1995","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014010242_ref45","first-page":"165","article-title":"Trends in AIDS incidence, death, and prevalence\u2014United States, 1996","volume":"46","author":"Centers for Disease Control Prevention","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171014010242_ref46","volume-title":"HIV\/AIDS Surveillance Report. Reported AIDS Cases 1995\u20132000","author":"Connecticut Department of Public Health"},{"key":"key\n\t\t\t\t20171014010242_ref47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0033-3549(04)50273-X","article-title":"Factors associated with positive HIV serostatus among women who use drugs: continued evidence for expanding factors of influence","volume":"118","author":"Theall","year":"2003","journal-title":"Public Health Rep"},{"key":"key\n\t\t\t\t20171014010242_ref48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1089\/apc.1997.11.62","article-title":"STDs, HIV, and crack cocaine: a review","volume":"11","author":"Wilson","year":"1997","journal-title":"AIDS Patient Care STDs"},{"key":"key\n\t\t\t\t20171014010242_ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v22n02_01","article-title":"Use of emergency room services by out-of-treatment drug users in Long Beach, California","volume":"22","author":"Reynolds","year":"2003","journal-title":"J Addict Dis"},{"key":"key\n\t\t\t\t20171014010242_ref50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0899-3289(01)00064-5","article-title":"Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users","volume":"13","author":"Metsch","year":"2001","journal-title":"J Subst Abuse"},{"key":"key\n\t\t\t\t20171014010242_ref51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-200203290-00012","article-title":"Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic","volume":"16","author":"Lucas","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014010242_ref52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/jurban\/jtg053","article-title":"Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users","volume":"80","author":"Altice","year":"2003","journal-title":"J Urban Health"},{"key":"key\n\t\t\t\t20171014010242_ref53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00042560-200109010-00008","article-title":"Trust and the acceptance of and adherence to antiretroviral therapy","volume":"28","author":"Altice","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014010242_ref54","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-2915-3_5","article-title":"The randomization process","volume-title":"Fundamentals of clinical trials","author":"Friedman","year":"1998","edition":"3rd ed."},{"key":"key\n\t\t\t\t20171014010242_ref55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bmj.290.6461.39","article-title":"Current issues in the design and interpretation of clinical trials","volume":"290","author":"Pocock","year":"1985","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20171014010242_ref56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042560-199801010-00005","article-title":"Repeated emergency department use by HIV-infected persons: effect of clinic accessibility and expertise in HIV care","volume":"17","author":"Markson","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key\n\t\t\t\t20171014010242_ref57","first-page":"647","article-title":"Project MotherCare: one hospital's response to the high perinatal death rate in New Haven, CT","volume":"109","author":"Reguero","year":"1994","journal-title":"Public Health Rep"},{"key":"key\n\t\t\t\t20171014010242_ref58","first-page":"535","article-title":"\"Medicine on wheels\": an opportunity for outreach and housestaff education","volume":"58","author":"Barry","year":"1994","journal-title":"Conn Med"},{"key":"key\n\t\t\t\t20171014010242_ref59","first-page":"135","article-title":"Two interventions to improve use of screening for breast cancer","volume":"293","author":"Schymura","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"key\n\t\t\t\t20171014010242_ref60","first-page":"163","article-title":"HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange","volume":"5","author":"Kaplan","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014010242_ref61","first-page":"36","article-title":"Workshop report: AIDS and stigma: a conceptual framework and research agenda","volume":"13","author":"Herek","year":"1998","journal-title":"AIDS Public Policy J"},{"key":"key\n\t\t\t\t20171014010242_ref62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1525-1446.2002.19504.x","article-title":"Effectiveness of a mobile medical van in providing screening services for STDs and HIV","volume":"19","author":"Liebman","year":"2002","journal-title":"Public Health Nurs"},{"key":"key\n\t\t\t\t20171014010242_ref63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00042560-200109010-00008","article-title":"Trust and the acceptance of and adherence to antiretroviral therapy","volume":"28","author":"Altice","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014010242_ref64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00042560-199808010-00005","article-title":"Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility","volume":"18","author":"Mostashari","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key\n\t\t\t\t20171014010242_ref65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1468-1293.2001.00054.x","article-title":"Characteristics of doctor-patient relationship and implication on adherence to antiretroviral treatments","volume":"2","author":"Martini","year":"2001","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20171014010242_ref66","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/338255","article-title":"Daily dosing of highly active antiretroviral therapy","volume":"34","author":"Rosenbach","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014010242_ref67","first-page":"90","article-title":"Efficacy and safety of once-daily antiretroviral therapy","volume":"12","author":"Boyle","year":"2002","journal-title":"AIDS Reader"},{"key":"key\n\t\t\t\t20171014010242_ref68","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2105\/AJPH.86.8_Pt_1.1146","article-title":"Directly observed therapy for tuberculosis: the Harlem Hospital experience, 1993","volume":"86","author":"El-Sadr","year":"1996","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20171014010242_ref69","article-title":"The IMB model of adherence","volume-title":"Presented at: 1st International Workshop on the Information-Motivation-Behavioral Skills Model","author":"Fisher","year":"2001"},{"key":"key\n\t\t\t\t20171014010242_ref70","article-title":"An information-motivation-behavior skills model of adherence to highly active antiretroviral therapy","volume-title":"Paper presented at: AIDS Impact: Biopsychosocial Aspects of HIV Infection, Fifth International Conference, Brighton, United Kingdom, July 8\u201311","author":"Fisher","year":"2001"},{"key":"key\n\t\t\t\t20171014010242_ref71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1055329002250996","article-title":"Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study","volume":"14","author":"DiIorio","year":"2003","journal-title":"J Assoc Nurses AIDS Care"},{"key":"key\n\t\t\t\t20171014010242_ref72","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1037\/0022-006X.71.4.754","article-title":"Motivational interviewing in drug abuse services: a randomized trial","volume":"71","author":"Miller","year":"2003","journal-title":"J Consult Clin Psychol"},{"key":"key\n\t\t\t\t20171014010242_ref73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00004479-199407000-00009","article-title":"Interventions to improve patient appointments in an ambulatory care facility","volume":"17","author":"Koren","year":"1994","journal-title":"J Ambulatory Care Manage"},{"issue":"Suppl 3","key":"key\n\t\t\t\t20171014010242_ref74","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00126334-200212153-00014","article-title":"Interventions to improve adherence to antiretroviral therapy","volume":"31","author":"Tuldra","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014010242_ref75","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1086\/368085","article-title":"Electronic human immunodeficiency virus (HIV) clinical reminder system improves adherence to practice guidelines among the University of Washington HIV Study Cohort","volume":"36","author":"Kitahata","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014010242_ref76","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/09540120310001618630","article-title":"Use of an on-line pager system to increase adherence to antiretroviral medications","volume":"15","author":"Safren","year":"2003","journal-title":"AIDS Care"},{"key":"key\n\t\t\t\t20171014010242_ref77","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jurban\/jtg044","article-title":"Impact of monetary incentives on adherence to referral for screening chest x-rays after syringe exchange-based tuberculin skin testing","volume":"80","author":"Perlman","year":"2003","journal-title":"J Urban Health"},{"key":"key\n\t\t\t\t20171014010242_ref78","first-page":"430","article-title":"The DOTS strategy in China: results and lessons after 10 years","volume":"80","author":"Xianyi","year":"2002","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20171014010242_ref79","first-page":"192","article-title":"Implementation of the DOTS strategy for tuberculosis in the Leningrad Region, Russian Federation (1998\u20131999)","volume":"6","author":"Ruohonen","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20171014010242_ref80","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1164\/ajrccm.156.5.96-12078","article-title":"Geographic diversity in tuberculosis trends and directly observed therapy, New York City, 1991 to 1994","volume":"156","author":"Davidow","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171014010242_ref81","article-title":"Genotypic resistance is less frequent in subject with poor adherence [abstract 460]","volume-title":"Proceedings of the 40th annual meeting of the Infectious Diseases Society of America (Chicago). 2002","author":"Howard","year":"2002"},{"key":"key\n\t\t\t\t20171014010242_ref82","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/00002030-200309050-00011","article-title":"High levels of adherence do not prevent accumulation of HIV drug resistance mutations","volume":"17","author":"Bangsberg","year":"2003","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014010242_ref83","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00002030-200003100-00008","article-title":"Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population","volume":"14","author":"Bangsberg","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014010242_ref84","first-page":"254","article-title":"Tuberculosis, poverty, and \u201ccompliance\u201d: lessons from rural Haiti","volume":"6","author":"Farmer","year":"1991","journal-title":"Semin Respir Infect"},{"key":"key\n\t\t\t\t20171014010242_ref85","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-96-3-297","article-title":"Successful supervised ambulatory management of tuberculosis treatment failures","volume":"96","author":"McDonald","year":"1982","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014010242_ref86","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-76-3-112-6-397","article-title":"USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability","volume":"112","author":"Combs","year":"1990","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014010242_ref87","first-page":"879","article-title":"DOTS and DOTS plus: what's in a name","volume":"5","author":"Aerts","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20171014010242_ref88","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/bmj.327.7407.164","article-title":"Impact of DOTS and DOTS-plus on multidrug resistant TB: DOTS-plus strengthens, not weakens, DOTS programmes","volume":"327","author":"Nardell","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171014010242_ref89","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/bmj.326.7389.574","article-title":"Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis","volume":"326","author":"Sterling","year":"2003","journal-title":"BMJ"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/38\/Supplement_5\/S376\/20905352\/38-Supplement_5-S376.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T15:17:29Z","timestamp":1705159049000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/38\/Supplement_5\/S376\/516866\/Developing-a-Directly-Administered-Antiretroviral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,1]]},"references-count":89,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2004,6,1]]},"published-print":{"date-parts":[[2004,6,1]]}},"URL":"https:\/\/doi.org\/10.1086\/421400","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,6,1]]},"published":{"date-parts":[[2004,6,1]]}}}